Johnson & Johnson
JNJ 256.48 (-0.10%) 0.26
EV: $673.68(B)
Total Equity: $84.97(B)
Debt/Equity: 0.58
Dividend/share: $5.2
Div. yield: 2.04%
P/E: 29.35
Forward P/E: 23.17
P/FCF: 27.76
P/S: 6.31
P/B: 7.27
EPS: $8.7
EPS (fwd): $11.1
FCF/share: $9.2
Revenue/share: $40.7
Book value/share: $35.3
ROIC: 21.7%
ROA: 13.5%
ROE: 33.6%
Margins: Gross | Op. | Net
68.1% | 26.2% | 21.5%
0.0%of Portfolio
My holdings
Day change
Total change
5Y Shares Out Change < 0% ROIC > 10% Debt/Equity < 1 Current Ratio > 1 Net Margin > 10% Est. EPS Growth > 5%
Quick Ratio > 1 Past Net Income CAGR > 0%
TTM Financials
Income (TTM)
Revenue$97.93(B)
Gross profit$66.73(B)
EBITDA$34.87(B)
Net income$21.04(B)
Gross margin68.1%
Operating margin26.2%
Net margin21.5%
Shares outstanding2.41(B)
Balance sheet
Total assets$201.06(B)
Current assets$59.77(B)
Total liabilities$116.09(B)
Current liabilities$54.90(B)
Cash & Short-term inv.$20.76(B)
Long-term debt$37.34(B)
Total intangibles$96.71(B)
PP&E$23.58(B)
Cash flow (TTM)
FCF$22.24(B)
CapEx$-5.36(B)
Dividends paid$-12.62(B)
Stock issued$4.39(B)
Stock repurchased$-8.07(B)
Stock-based comp.$1.41(B)
Debt issued$18.38(B)
Debt repaid$-19.95(B)